August 2026– date –
-
Endress+Hauser Boosts Single-Use Bioprocessing with Innovative Proline Promass U 500 Coriolis Flowmeter, Integrating Reusable Units with Disposable Sensors for Enhanced Flexibility
Endress+Hauser Switzerland Overview Endress+Hauser announced the Proline Promass U 500 Coriolis flowmeter as the latest innovation in single-use technology for bioprocessing. This groundbreaking technology combines a reusable base unit w... -
US Federal Approval for Cultivated Meat Advances: FDA and USDA Permit Sale of Cell-Cultivated Chicken, Contributing to Reduced Environmental Impact and Enhanced Food Supply
(Facebook post) USA Overview In the U.S., federal safety approvals for cultivated meat have advanced, with the FDA and USDA permitting the sale of specific cell-cultivated chicken products. This move highlights potential benefits like re... -
Bio-Link Report: Single-Use Systems Transform Vaccine Sterile Manufacturing into ‘Flexible Smart Manufacturing’, Achieving Enhanced Efficiency and Cost Reduction with 2000L+ Bioreactors
Bio-Link Unknown Overview A Bio-Link report states that single-use systems are transforming vaccine sterile manufacturing from a 'steel jungle' into 'flexible smart manufacturing.' These systems enable cost reduction, accelerated technol... -
AuctuPrime: AuctuCel’s Chemically Defined Medium Standardizes Cell Therapy Production, Slashing Variability
The Manila Times Philippines Overview Singapore-based AuctuCel, in collaboration with Sperikon, has launched AuctuPrime, a groundbreaking chemically defined cell culture medium. This next-generation formulation eliminates the need for an... -
Digital Twin Technology Revolutionizes Bioprocesses: Enabling Simulation-Based Optimization of Stirring Speed, Feed Rates, and Aeration to Reduce Risk and Cost
JojoImats (Facebook post) Unknown Overview A Facebook post by JojoImats highlights how digital twin technology is revolutionizing bioprocess development. This technology creates a faithful digital replica of physical systems like bioreac... -
Cell Grand Clinic in Japan Offers Non-Surgical Joint Pain Therapy: Culturing up to 200 Million Autologous Adipose-Derived Stem Cells over 7 Weeks for Direct Injection
Cell Grand Clinic Japan Overview Japan's Cell Grand Clinic announced its offering of a non-surgical joint pain therapy, involving the 7-week culture of autologous stem cells derived from a patient's fat, with up to 200 million cells inje... -
Xcellon Biologics Acquires NextCure’s 40,000-Square-Foot GMP Manufacturing Facility, Enhancing End-to-End CRDMO Capabilities for Next-Generation Bioconjugates and Complex Biologics
Outsourced Pharma USA Overview Xcellon Biologics has acquired NextCure's 40,000-square-foot GMP manufacturing facility, significantly bolstering its capabilities as an end-to-end CRDMO (Contract Research, Development, and Manufacturing O... -
Cellura Report: Human Pluripotent Stem Cell Culture Evolves, Building Next-Gen Manufacturing with Chemically Defined Xeno-Free Media, Advanced Biomaterials, Automated Production, and Intelligent Control
Cellura Unknown Overview Cellura reports a significant evolution in human pluripotent stem cell (hPSC) culture towards more reliable and reproducible cell manufacturing. This transformation is characterized by a shift to chemically defin... -
Cultivated Meat Faces Scientific, Sustainability, and Regulatory Hurdles: Microcarriers and Biomanufacturing Process Improvements are Critical
ResearchGate Unknown Overview A recent review highlights the major scientific, sustainability, and regulatory challenges confronting the cultivated meat industry. The study emphasizes the pivotal role of microcarriers as a key enabling t... -
Rapid Rise of iPSC-Based Therapies: Closed, Automated Cell Culture Systems Address Scalability and Cost Challenges for Allogeneic Treatments
Contract Pharma USA Overview Contract Pharma reported on the rapid advancements in iPSC-derived therapies, highlighting their potential as scalable solutions for allogeneic treatments and complex indications. The article details key chal...
